Not applicableUnknownNCT02904850What this trial is testingValidation of a Kinetic Model of ErlotinibWho this might be right forLung Cancer University Hospital, Strasbourg, France 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018063What this trial is testingNeoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric CancerWho this might be right forGastric (Cardia, Body) CancerStomach AdenocarcinomaLocally Advanced zhoujing 35
Testing effectiveness (Phase 2)UnknownNCT06304987What this trial is testingNeoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal CancerWho this might be right forLocally Advanced Rectal Cancer Beijing Friendship Hospital 50
Large-scale testing (Phase 3)Study completedNCT03764293What this trial is testingEvaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCCWho this might be right forLocally Advanced or Metastatic and Unresectable HCC Jiangsu HengRui Medicine Co., Ltd. 543
Testing effectiveness (Phase 2)UnknownNCT05130684What this trial is testingNeo-NTP-CRT for Locally Advanced ESCCWho this might be right forLocally Advanced Esophageal Squamous Cell Carcinoma National Taiwan University Hospital 43
Testing effectiveness (Phase 2)Study completedNCT00459875What this trial is testingSunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney CancerWho this might be right forKidney Cancer Memorial Sloan Kettering Cancer Center 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05132075What this trial is testingStudy of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Novartis Pharmaceuticals 95
Testing effectiveness (Phase 2)UnknownNCT06237257What this trial is testingChemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical CancerWho this might be right forLocally Advanced Cervical Cancer Shanghai Shengdi Pharmaceutical Co., Ltd 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Not applicableUnknownNCT04810936What this trial is testingEarly Nutritional Intervention in NPC Patients Undergoing Concurrent ChemoradiotherapyWho this might be right forMalnutritionNasopharyngeal Carcinoma Guangdong Provincial People's Hospital 272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07388836What this trial is testingTiming Optimization of Immunotherapy During Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal CarcinomaWho this might be right forLocally Advanced Nasopharyngeal Carcinoma Fujian Cancer Hospital 198
Not applicableStudy completedNCT01598597What this trial is testingAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)Who this might be right forBreast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more Genentech, Inc. 276
Not applicableNot Yet RecruitingNCT07183124What this trial is testing3D Modeling for Detecting Locally Advanced Rectal Cancer With Positive Circumferential Resection MarginWho this might be right forGeneral SurgeryOncologyMedical Informatics Taichung Veterans General Hospital 1,500
Testing effectiveness (Phase 2)Looking for participantsNCT05254327What this trial is testingTrial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001Who this might be right forRectal Cancer University of Nebraska 118
Large-scale testing (Phase 3)Looking for participantsNCT07185997What this trial is testingStudy to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsWho this might be right forNon-Small-Cell Lung CancerMetastatic Non-Small-Cell Lung CancerAdvanced Non-Small-Cell Lung Cancer+3 more ArriVent BioPharma, Inc.
Testing effectiveness (Phase 2)Study completedNCT02725424What this trial is testingOptimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal CancerWho this might be right forGastric Cancer Chinese Academy of Medical Sciences 180
Early research (Phase 1)Looking for participantsNCT05614739What this trial is testingFORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3Who this might be right forUrinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms Eli Lilly and Company 677
Testing effectiveness (Phase 2)Ended earlyNCT01234519What this trial is testingA Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapyWho this might be right forUrothelial Carcinoma AEterna Zentaris 12
Early research (Phase 1)Study completedNCT01379339What this trial is testingCabazitaxel - PF Induction ChemotherapyWho this might be right forSquamous Cell Carcinoma of the Head and Neck Krzysztof Misiukiewicz 40
Testing effectiveness (Phase 2)Study completedNCT00001239What this trial is testingCombination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast CancerWho this might be right forBreast CancerBreast Neoplasms National Cancer Institute (NCI) 100